Solstice Oncology, Inc.

Form D Filings

Location
Boston, MA
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0002116600
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
3/9/2026 Equity, Option to Acquire, Security to be Acquired $121,260,306 $298,400,851 $177,140,545 2/20/2026 3/9/2026 D 000211660026000002